ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "JACC - August 27, 2024 Issue Summary"
Episode Synopsis
In this episode, Dr. Valentin Fuster covers four original papers focusing on cardiovascular disease. Highlights include the effectiveness of semaglutide in reducing weight and improving heart failure symptoms, long-lasting effects of OPASAN on lipoprotein(a) levels, the impact of low-dose rivaroxaban plus aspirin on fragile patients post-revascularization, and the promising use of AI-based ECG for predicting biventricular dysfunction in congenital heart disease.
More episodes of the podcast JACC This Week
December 2, 2025: Global CVD 1990–2023: Trends, Risks, and the Road Ahead | JACC This Week
24/11/2025
November 18, 2025: Adiposity, Heart Failure, and the Future of Cardiometabolic Care | JACC This Week
10/11/2025
November 11, 2025: Precision, Place, and the Future of Cardiovascular Prediction | JACC This Week
03/11/2025
In God we trust